CHINA Six COVID-19 vaccines in Phase 3 clinical trials in China: medicine regulator

CHINA

Six COVID-19 vaccines in Phase 3 clinical trials in China: medicine regulator

CGTN

12:45, February 19, 2021

China has granted conditional commercial approval for two COVID-19 vaccines, and six of 16 vaccines given emergency permission for clinical trials have entered Phase 3 trials, the National Medical Products Administration (NMPA) said Friday.

A staff member checks the packaging quality of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Photo: Xinhua)

The regulatory body said it has given conditional commercial approval for two drugs and permitted clinical trials of 22 drugs for treating and preventing COVID-19 and related indications.

The NMPA has also issued emergency authorization to 54 test reagents for the novel coronavirus. It said China has reached a daily capacity of manufacturing reagents to test over 24 million people.


Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue